Single gene


The MetDETECT™ assay evaluates the MET tyrosine kinase receptor locus and surrounding regions using next-generation sequencing at extremely high coverage to identify mutant alleles for prediction of therapeutic response. The MetDetect™ assay can be applied to both plasma and tumor tissue samples to identify MET amplification that occurs in small percentage of DNA molecules (0.10%).

MetDETECT™ Key Metrics
Regions AnalyzedFocal amplification of MET
Sequencing MethodIllumina next generation sequencing
BioinformaticsPatented PARE and Digital Karyotyping methods
Assay Sensitivity100% (95% CI, 48%-100%): detection capability 0.10%
Assay Specificity100% (95% CI, 85%-100%)
Sequencing Coverage2,000x
Turn-around Time3 weeks
Sample RequirementsBlood or tumor tissue
Sample TypesPlasma or frozen tumor, FFPE, cell lines,
and xenografts
Plasma Sample Input3-5 ml (minimum 1 ml)
Tumor Sample
Input Required
1 µg (minimum 50 ng)

PlasmaSELECT™ 64

PlasmaSELECT™ analyzes circulating tumor DNA for genetic alterations in cancer, eliminating the need for an invasive biopsy or tumor tissue. PlasmaSELECT™ may also be used to evaluate sub-clonal mutations in tumor tissue, when available. PlasmaSELECT™ evaluates a targeted panel of 64 well-characterized cancer genes. Cell-free DNA is extracted from plasma and prepared using proprietary methods that accommodate low abundance sample DNA. Samples are processed using a proprietary capture process and high coverage next-generation sequencing to allow tumor-specific (somatic) mutations, microsatellite instability (MSI) and translocations to be identified with a high sensitivity and specificity. Analyses for sequence mutations or rearrangements can be performed together or separately, depending on the specific alterations of interest.

PlasmaSELECT™ 64 Key Metrics
Regions Analyzed64 Genes
Sequencing MethodIllumina next-generation sequencing
BioinformaticsPatented PARE, Digital Karyotyping and VariantDx
Turn-around Time2-3 weeks
Sample RequirementsWhole blood or plasma
Sample Input RequiredTwo 10 ml tubes of peripheral whole blood; 6-10 ml plasma collected according to PGDx sample preparation instructions (>1-2ml for RUO)